INTRAGLOMERULAR FOAM CELLS AND HUMAN FOCAL GLOMERULOSCLEROSIS

被引:29
作者
SCHONHOLZER, KW
WALDRON, M
MAGIL, AB
机构
[1] VANCOUVER GEN HOSP,DEPT MED,VANCOUVER V5Z 1M9,BC,CANADA
[2] VANCOUVER GEN HOSP,DEPT PEDIAT,VANCOUVER V5Z 1M9,BC,CANADA
[3] VANCOUVER GEN HOSP,DEPT PATHOL,VANCOUVER V5Z 1M9,BC,CANADA
[4] CHILDRENS HOSP,VANCOUVER,BC,CANADA
[5] UNIV BRITISH COLUMBIA,VANCOUVER V6T 1W5,BC,CANADA
来源
NEPHRON | 1992年 / 62卷 / 02期
关键词
MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL-CHANGE DISEASE; SERUM LIPIDS; SEGMENTAL SCLEROSIS;
D O I
10.1159/000187020
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Experimental evidence suggests a pathogenetic role for lipids in focal glomerulosclerosis (FGS) analogous to atherosclerosis. As foam cells (FC) are an important factor in atherosclerosis, a retrospective comparative study was done to evaluate the significance of intraglomerular FC in human FGS. Glomerular FC infiltration was evaluated in 115 biopsies of FGS, 120 biopsies of membranous glomerulonephritis (MGN) and 50 biopsies of minimal-change disease (MCD). Selected clinical and laboratory data collected at about the time of biopsy were reviewed. The proportion of biopsies showing glomerular FC was much higher in FGS (70%) than in either MGN (12%) or MCD (0%) p < 0.001. The mean percent (+/-SD) of glomeruli with FC per biopsy was significantly greater in FGS (7.9+/-9.9) than in MGN (2.0+/-7.8; p < 0.0001). Of the 14 MGN biopsies with FC, 13 showed superimposed FGS. Mean serum total cholesterol and triglyceride were not significantly higher in FGS than in either MGN or MCD. The results demonstrate a close association of glomerular FC infiltration with FGS.
引用
收藏
页码:130 / 136
页数:7
相关论文
共 46 条
[1]   THERAPEUTIC ADVANTAGE OF CONVERTING ENZYME-INHIBITORS IN ARRESTING PROGRESSIVE RENAL-DISEASE ASSOCIATED WITH SYSTEMIC HYPERTENSION IN THE RAT [J].
ANDERSON, S ;
RENNKE, HG ;
BRENNER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) :1993-2000
[2]   THE HYPERLIPIDEMIA OF THE NEPHROTIC SYNDROME - RELATION TO PLASMA-ALBUMIN CONCENTRATION, ONCOTIC PRESSURE, AND VISCOSITY [J].
APPEL, GB ;
BLUM, CB ;
CHIEN, S ;
KUNIS, CL ;
APPEL, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (24) :1544-1548
[3]   SERUM LIPID AND LIPOPROTEIN ALTERATIONS IN NEPHROSIS [J].
BAXTER, JH ;
GOODMAN, HC ;
HAVEL, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 1960, 39 (03) :455-465
[4]   FOCAL GLOMERULOSCLEROSIS - NATURAL-HISTORY AND TREATMENT - REPORT OF 70 CASES [J].
BEAUFILS, H ;
ALPHONSE, JC ;
GUEDON, J ;
LEGRAIN, M .
NEPHRON, 1978, 21 (02) :75-85
[5]  
Bohle A, 1977, Curr Top Pathol, V65, P81
[6]   HYPERLIPEMIA IN UNTREATED NEPHROTIC SYNDROME, INCREASED PRODUCTION OR DECREASED REMOVAL [J].
CHAN, MK ;
PERSAUD, JW ;
RAMDIAL, L ;
VARGHESE, Z ;
SWENY, P ;
MOORHEAD, JF .
CLINICA CHIMICA ACTA, 1981, 117 (03) :317-323
[7]  
CHURG J, 1970, LANCET, V1, P1299
[8]  
CHURG J, 1982, CLASSIFICATION ATLAS, P54
[9]   ESSENTIAL FATTY-ACID DEFICIENCY DURING ACUTE PUROMYCIN NEPHROSIS AMELIORATES LATE RENAL INJURY [J].
DIAMOND, JR ;
PESEK, I ;
RUGGIERI, S ;
KARNOVSKY, MJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (05) :F798-F807
[10]   FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS - ANALOGIES TO ATHEROSCLEROSIS [J].
DIAMOND, JR ;
KARNOVSKY, MJ .
KIDNEY INTERNATIONAL, 1988, 33 (05) :917-924